annual EBIT:
$97.87M+$92.69M(+1787.92%)Summary
- As of today (May 29, 2025), SUPN annual earnings before interest & taxes is $97.87 million, with the most recent change of +$92.69 million (+1787.92%) on December 31, 2024.
- During the last 3 years, SUPN annual EBIT has risen by +$1.27 million (+1.32%).
- SUPN annual EBIT is now -49.13% below its all-time high of $192.40 million, reached on December 31, 2020.
Performance
SUPN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$2.60M-$28.98M(-109.84%)Summary
- As of today (May 29, 2025), SUPN quarterly earnings before interest & taxes is -$2.60 million, with the most recent change of -$28.98 million (-109.84%) on March 31, 2025.
- Over the past year, SUPN quarterly EBIT has increased by +$1.65 million (+38.89%).
- SUPN quarterly EBIT is now -104.42% below its all-time high of $58.80 million, reached on September 30, 2020.
Performance
SUPN quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$95.03M+$1.65M(+1.77%)Summary
- As of today (May 29, 2025), SUPN TTM earnings before interest & taxes is $95.03 million, with the most recent change of +$1.65 million (+1.77%) on March 31, 2025.
- Over the past year, SUPN TTM EBIT has increased by +$104.62 million (+1091.35%).
- SUPN TTM EBIT is now -50.84% below its all-time high of $193.30 million, reached on September 30, 2020.
Performance
SUPN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SUPN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1787.9% | +38.9% | +1091.3% |
| 3 y3 years | +1.3% | -115.6% | -1.3% |
| 5 y5 years | -42.5% | -107.5% | -45.6% |
SUPN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1787.9% | -105.8% | +84.0% | -1.3% | +1091.3% |
| 5 y | 5-year | -49.1% | +1787.9% | -104.4% | +84.0% | -50.8% | +1091.3% |
| alltime | all time | -49.1% | +215.9% | -104.4% | +89.7% | -50.8% | +212.6% |
SUPN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$2.60M(-109.8%) | $95.03M(+1.8%) |
| Dec 2024 | $97.87M(+1787.9%) | $26.38M(-41.3%) | $93.38M(+37.3%) |
| Sep 2024 | - | $44.94M(+70.9%) | $67.99M(+106.4%) |
| Jun 2024 | - | $26.30M(-719.2%) | $32.93M(-443.6%) |
| Mar 2024 | - | -$4.25M(-529.1%) | -$9.59M(-284.9%) |
| Dec 2023 | $5.18M(-92.4%) | $990.00K(-90.0%) | $5.18M(-87.3%) |
| Sep 2023 | - | $9.89M(-161.0%) | $40.93M(+26.6%) |
| Jun 2023 | - | -$16.22M(-254.1%) | $32.32M(-47.6%) |
| Mar 2023 | - | $10.52M(-71.4%) | $61.67M(-9.1%) |
| Dec 2022 | $67.81M(-29.8%) | $36.73M(+2769.8%) | $67.81M(+73.6%) |
| Sep 2022 | - | $1.28M(-90.3%) | $39.06M(-46.2%) |
| Jun 2022 | - | $13.13M(-21.2%) | $72.67M(-24.5%) |
| Mar 2022 | - | $16.66M(+108.7%) | $96.24M(-0.4%) |
| Dec 2021 | $96.60M(-49.8%) | $7.99M(-77.1%) | $96.60M(-28.1%) |
| Sep 2021 | - | $34.88M(-5.0%) | $134.40M(-15.1%) |
| Jun 2021 | - | $36.70M(+115.6%) | $158.32M(-9.3%) |
| Mar 2021 | - | $17.03M(-62.8%) | $174.64M(-9.2%) |
| Dec 2020 | $192.40M(+13.0%) | $45.79M(-22.1%) | $192.40M(-0.5%) |
| Sep 2020 | - | $58.80M(+10.9%) | $193.30M(+7.5%) |
| Jun 2020 | - | $53.02M(+52.4%) | $179.75M(+2.8%) |
| Mar 2020 | - | $34.79M(-25.5%) | $174.87M(+2.7%) |
| Dec 2019 | $170.19M(+7.5%) | $46.69M(+3.2%) | $170.19M(+1.4%) |
| Sep 2019 | - | $45.25M(-6.0%) | $167.86M(+2.0%) |
| Jun 2019 | - | $48.13M(+59.9%) | $164.55M(+5.6%) |
| Mar 2019 | - | $30.11M(-32.1%) | $155.80M(-1.6%) |
| Dec 2018 | $158.29M(+54.9%) | $44.37M(+5.8%) | $158.29M(+6.1%) |
| Sep 2018 | - | $41.94M(+6.5%) | $149.13M(+14.5%) |
| Jun 2018 | - | $39.38M(+20.8%) | $130.25M(+10.8%) |
| Mar 2018 | - | $32.60M(-7.4%) | $117.51M(+15.0%) |
| Dec 2017 | $102.19M | $35.21M(+52.6%) | $102.19M(+22.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $23.07M(-13.4%) | $83.48M(+3.4%) |
| Jun 2017 | - | $26.64M(+54.3%) | $80.76M(+21.9%) |
| Mar 2017 | - | $17.27M(+4.7%) | $66.25M(+19.5%) |
| Dec 2016 | $55.46M(+186.2%) | $16.50M(-18.9%) | $55.46M(+17.4%) |
| Sep 2016 | - | $20.34M(+67.7%) | $47.26M(+46.5%) |
| Jun 2016 | - | $12.13M(+87.2%) | $32.27M(+35.0%) |
| Mar 2016 | - | $6.48M(-21.9%) | $23.90M(+23.3%) |
| Dec 2015 | $19.38M(-514.6%) | $8.30M(+55.2%) | $19.38M(+13.9%) |
| Sep 2015 | - | $5.35M(+42.0%) | $17.02M(+55.9%) |
| Jun 2015 | - | $3.77M(+91.8%) | $10.91M(-6.1%) |
| Mar 2015 | - | $1.96M(-66.9%) | $11.63M(-348.8%) |
| Dec 2014 | -$4.67M(-94.5%) | $5.94M(-885.6%) | -$4.67M(-84.9%) |
| Sep 2014 | - | -$756.00K(-116.9%) | -$30.91M(-39.8%) |
| Jun 2014 | - | $4.48M(-131.3%) | -$51.38M(-36.6%) |
| Mar 2014 | - | -$14.34M(-29.4%) | -$81.07M(-4.0%) |
| Dec 2013 | -$84.42M(+97.7%) | -$20.30M(-4.4%) | -$84.42M(+9.9%) |
| Sep 2013 | - | -$21.23M(-15.8%) | -$76.83M(+12.6%) |
| Jun 2013 | - | -$25.21M(+42.6%) | -$68.21M(+31.0%) |
| Mar 2013 | - | -$17.69M(+39.2%) | -$52.08M(+21.9%) |
| Dec 2012 | -$42.71M(+13.6%) | -$12.71M(+0.8%) | -$42.71M(+6.5%) |
| Sep 2012 | - | -$12.60M(+38.7%) | -$40.10M(+7.2%) |
| Jun 2012 | - | -$9.08M(+9.2%) | -$37.41M(+1.9%) |
| Mar 2012 | - | -$8.31M(-17.6%) | -$36.72M(-2.8%) |
| Dec 2011 | -$37.60M(-4.7%) | -$10.10M(+1.8%) | -$37.76M(-19.8%) |
| Sep 2011 | - | -$9.91M(+18.1%) | -$47.08M(+26.7%) |
| Jun 2011 | - | -$8.40M(-10.3%) | -$37.17M(+29.2%) |
| Mar 2011 | - | -$9.36M(-51.8%) | -$28.77M(+48.2%) |
| Dec 2010 | -$39.47M(-1053.9%) | -$19.41M(+41.5%) | -$19.41M(+41.5%) |
| Dec 2009 | $4.14M(-116.7%) | -$13.72M | -$13.72M |
| Dec 2008 | -$24.80M(+43.6%) | - | - |
| Dec 2007 | -$17.27M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual EBIT year-on-year change?
- What is Supernus Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly EBIT year-on-year change?
- What is Supernus Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM EBIT year-on-year change?
What is Supernus Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of SUPN is $97.87M
What is the all time high annual EBIT for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual earnings before interest & taxes is $192.40M
What is Supernus Pharmaceuticals annual EBIT year-on-year change?
Over the past year, SUPN annual earnings before interest & taxes has changed by +$92.69M (+1787.92%)
What is Supernus Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of SUPN is -$2.60M
What is the all time high quarterly EBIT for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly earnings before interest & taxes is $58.80M
What is Supernus Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, SUPN quarterly earnings before interest & taxes has changed by +$1.65M (+38.89%)
What is Supernus Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of SUPN is $95.03M
What is the all time high TTM EBIT for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM earnings before interest & taxes is $193.30M
What is Supernus Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, SUPN TTM earnings before interest & taxes has changed by +$104.62M (+1091.35%)